Ticagrelor [Cas No. 274693-27-5]
Catalog No：TA-T0179
Manufacturer：TargetMol
Synonyms：AZD6140,AR-C 126532XX
CAS No.：274693-27-5
Formula：C23H28F2N6O4S
MWt：522.57
€54,00 – €173,00
| Name: | Ticagrelor |
| Category: | Biochemicals |
| Description: | Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU). |
| Pathway: | Metabolism, Neuroscience, Others |
| Target: | Others antagonist, P2 Receptor inhibitor, P450 antagonist |
| Receptor: | Midazolam 4-hydroxylation, P2Y12, CYP2C9 |
Help & Support
Product
Guarantee and
Expert Support
Related products
Catalog No：TA-PDK0327
Manufacturer：TargetMol
CAS No.：6638-05-7
MWt：168.2
€30,00 – €50,00
Catalog No：TA-Fr16745
Manufacturer：TargetMol
CAS No.：14191-95-8
Formula：C8H7NO
MWt：133.15
€42,00 – €50,00
Catalog No：TA-Fr16605
Manufacturer：TargetMol
CAS No.：486-70-4
Formula：C10H19NO
MWt：169.3
€50,00 – €1.980,00
Catalog No：TA-Fr13883
Manufacturer：TargetMol
CAS No.：1798-09-0
Formula：C9H10O3
MWt：166.18
€42,00 – €50,00
Catalog No：TA-Fr12290
Manufacturer：TargetMol
CAS No.：20280-81-3
Formula：C10H8O3
MWt：176.17
€50,00 – €60,00